INTERNATIONAL PATENT: EFFEPHARM (SHANGHAI) CO., LTD., 音芙医药科技（上海）有限公司 FILES APPLICATION FOR "PHARMACEUTICAL USE OF REDUCED Β-NICOTINAMIDE MONONUCLEOTIDE"

GENEVA, Oct. 26 -- EFFEPHARM (SHANGHAI) CO., LTD. (Room 201, Building 12, No.1 Wangdong Middle Road, Sijing TownSongjiang District, Shanghai 201601), 音芙医药科技（上海）有限公司 (中国上海市松江区泗泾镇望东中路1号12幢201室) filed a patent application (PCT/CN2025/074350) for "PHARMACEUTICAL USE OF REDUCED Beta-NICOTINAMIDE MONONUCLEOTIDE" on Jan 23, 2025. With publication no. WO/2025/218307, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classific...